Keck Medicine of USC Announces New Measures to Combat COVID-19

Keck Hospital implements no-visitor policy and extends screening for all patients
Keck Medicine of USC
19-Mar-2020 10:30 AM EDT, by Keck Medicine of USC contact patient services

Newswise — LOS ANGELES – Keck Medicine of USC has taken many precautions to protect patients and staff in light of the COVID-19 pandemic. In response to the growing number of cases in California, the health system is taking several new measures to combat the virus: 

 New Procedures:

  • Many elective inpatient and outpatient surgeries will be rescheduled on a case-by-case basis. 
  • Keck Medicine has established an isolated screening facility for health care workers and patients exhibiting viral symptoms at its Keck Hospital of USC location. 
  • An increased number of patients are using telemedicine for appointments. 

New Preventive Measures: 

  • Keck Hospital and USC Norris Cancer Hospital have initiated a no-visitor policy for admitted patients, with exceptions for patients who are at end of life or other critical situations. 
  • Keck Medical Center of USC buildings have limited entry points and fever screenings are taking place at all clinical entry points. Visitors to outpatient locations will be screened for fever upon check-in. 
  • Anyone with respiratory symptoms or fever will be given a mask and redirected based on assessment of their clinical condition.
  • Medical students at the Keck School of Medicine of USC have been pulled from clinical rounds and from working directly with patients at Keck Medicine clinical locations.

“As COVID-19 spreads, we will continue to take all necessary precautions to protect our patients, staff and community and to effectively manage this virus,” says Rodney Hanners, COO of Keck Medicine and CEO of Keck Medical Center. “All of our efforts right now are directed at developing procedures and protocols to provide our patients and community with compassionate care while ensuring their safety.”

Learn more about Keck Medicine COVID-19 efforts by visiting its COVID-19 website. For more information about how USC is handling the outbreak, please visit usc.edu.

 # # #

 Editor’s Note:  Hanners is available for media interviews.  For an interview, please contact Meg Aldrich at meg.aldrich@med.usc.edu.

  

About Keck Medicine of USC

Keck Medicine of USC is one of only two university-based medical systems in the Los Angeles area. Its internationally renowned physicians and scientists provide world-class patient care at Keck Hospital of USC, USC Norris Cancer Hospital, USC Verdugo Hills Hospital and more than 80 outpatient clinics in Los Angeles, Orange, Kern, Tulare and Ventura counties.

Keck Medical Center was ranked No. 16 on U.S. News & World Report’s 2019-20 Best Hospital Honor Roll and among the top 3 hospitals in Los Angeles and top 5 in California. The hospital also ranked in the top 4 in urology (tie); top 10 in geriatrics; top 15 in ophthalmology, cardiology & heart surgery, gastroenterology & GI surgery and nephrology; top 20 in neurology & neurosurgery; top 25 in cancer; and top 35 in pulmonology & lung surgery.

For more information, visit KeckMedicine.org.




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.23796